Riik: Iisrael
keel: inglise
Allikas: Ministry of Health
MONTELUKAST AS SODIUM
CTS CHEMICAL INDUSTRIES LTD, ISRAEL
R03DC03
CHEWABLE TABLETS
MONTELUKAST AS SODIUM 5 MG
PER OS
Required
CTS CHEMICAL INDUSTRIES LTD, ISRAEL
MONTELUKAST
MONTELUKAST
Montair 5 mg is indicated in adult and pediatric patients 6 years of age and older for the prophylaxis and chronic treatment of asthma, including prevention of daytime and nighttime symptoms, the treatment of aspirin-sensitive asthmatic patients, and the prevention of exercise-induced bronchoconstriction.Montair 5 mg is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma.Montair 5 mg and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability.Montair 5 mg is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and pediatric patients 2 years of age and older.
2016-02-29
PATIENT LEAFLET IN ACCORDANCE WITH THE PHARMACISTS’ REGULATIONS (PREPARATIONS) – 1986 The medicine is dispensed with a doctor’s prescription only MONTAIR 4 MG CHEWABLE TABLETS MONTAIR 5 MG CHEWABLE TABLETS Each MONTAIR 4 mg tablet contains: Montelukast (as sodium) 4 mg Each MONTAIR 5 mg tablet contains: Montelukast (as sodium) 5 mg For a list of inactive ingredients and allergens in the preparation – see section 2 “Important information regarding some of the ingredients of the medicine” and section 6 “Additional information”. READ THE ENTIRE LEAFLET CAREFULLY BEFORE USING THE MEDICINE. • This leaflet contains concise information about MONTAIR. If you have other questions, ask the doctor or pharmacist. • This medicine has been prescribed for your treatment. Do not pass it on to others. It may harm them even if it seems that their medical condition is similar to yours. WHAT IS THE MOST IMPORTANT INFORMATION I SHOULD KNOW ABOUT MONTAIR? • SEVERE MENTAL HEALTH PROBLEMS HAVE BEEN REPORTED IN PEOPLE TAKING MONTAIR or even after stopping the treatment. This can happen in people with or without a history of mental health problems. Stop taking MONTAIR and immediately tell your doctor if you or your child are experiencing unusual changes in behavior or thinking, including any of the following symptoms: Agitation, including aggressive behavior or hostility, attention disorders, bad or vivid dreams, depression, disorientation (confusion), feeling of anxiety, irritability, hallucinations (seeing or hearing non-existing things), memory impairment, obsessive-compulsive symptoms, restlessness, sleep-walking, stuttering, suicidal thoughts and actions (including suicide), tremor, insomnia, uncontrolled muscle movements. 1. WHAT IS MONTAIR AND WHAT IS IT USED FOR? MONTAIR is indicated for the prevention and chronic treatment of asthma, including prevention of daytime and nighttime symptoms, treatment of aspirin-sensitive asthmatic patients and prevention of exercise-induced bronchoconstriction in adult patient Lugege kogu dokumenti